Steady Expansion Forecast for Small Volume Parenteral Market, Projected to Reach $258.88 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Small Volume Parenteral Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for small volume parenteral has seen significant expansion lately. The growth is expected to continue, rising from $177.26 billion in 2024 to approximately $191.36 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth in the preceding years include increasing instances of chronic diseases, official regulatory approvals and government programs, the trend of outsourcing in the pharmaceutical industry, and the globalization and growth of pharmaceutical markets.

Small Volume Parenteral Market Size Forecast: What's the Projected Valuation by 2029?
The market size for small volume parenteral is projected to witness significant expansion in the upcoming years, reaching a value of $258.88 billion in 2029, bolstered by a compound annual growth rate (CAGR) of 7.8%. This surge during the forecast period can be credited to several factors such as the augmentation of the biologics market, improvements in healthcare infrastructure, rising rates of hospitalization, regulatory greenlights, movement towards home healthcare, increased healthcare investments, and global health emergencies. The predicted period also foresees growth in biocompatible formulations, patient-oriented strategies, the development of home healthcare, breakthroughs in automated manufacturing, furtherance in therapeutic areas, and the innovation of smart pump technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

What Are the Drivers Transforming the Small Volume Parenteral Market?
The growth of the small-volume parenteral market is expected to be fueled by the rising number of surgeries. Surgical procedures, which involve the use of operative techniques to treat or investigate pathological conditions, improve bodily function or aesthetics, and repair ruptured areas, are a critical medical specialty. The surge in surgical procedures is attributed to advancements in medical technology and an aging population, consequently increasing the need for surgical interventions. Small-volume parenteral solutions, utilized during surgeries for precise administration of medications, electrolytes, and nutrients right into the bloodstream, find robust demand. For example, as reported by The Aesthetic Society, a US organization of plastic surgery and cosmetic medicine, in August 2023, Americans spent over $11.8 billion on aesthetic procedures overall, marking a 2% increase from the previous year. Therefore, the small-volume parenteral market's growth is propelled by the escalating number of surgeries.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp

What Are the Key Trends Driving Small Volume Parenteral Market Growth?
Key players in the small volume parenteral market are concentrating their efforts on innovating novel solutions, for instance, incorporating built-in lyophilizers to boost their market earnings. A built-in lyophilizer signifies the inclusion of a drying and freezing system in the process line to create lyophilized powders, frequently utilized for specific parenteral drugs. A real-life example is WuXi STA, a pharmaceutical firm based in China, which introduced a parenteral formulation manufacturing line in January 2022. This fresh manufacturing line, combined with the sterilized manufacturing facility in Wuxi, meets the cGMP standards set by authoritative bodies like U.S. FDA, EMA, and China NMPA. It boasts state-of-the-art isolation systems and filling machinery in its sector. Robotic technology conducts the entire filling process within a fully secluded area, which is specially crafted to limit human interference and prevent contamination, which thereby ensures high product quality.

Which Segments in the Small Volume Parenteral Market Offer the Most Profit Potential?
The small volume parenteral market covered in this report is segmented -

1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users

Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15925&type=smp

Which Firms Dominate the Small Volume Parenteral Market by Market Share and Revenue in 2025?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

Which Regions Offer the Highest Growth Potential in the Small Volume Parenteral Market?
North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15925

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.